Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Clearlake Capital Group and Insight Partners’ $4.4 Billion Acquisition of Alteryx
Sidley Austin is advising Clearlake on the transaction, and Willkie Farr & Gallagher is advising Insight, while Wilson Sonsini Goodrich & Rosati and Fenwick & West...
Helbiz’s Acquisition of Wheels Labs
Fenwick represented Wheels Labs on the deal. Wheels Labs, a last-mile, shared electric mobility platform using proprietary vehicles with integrated helmet technology, announced its acquisition by Helbiz,...
zSpace’s Merger Agreement with EdtechX Holdings Acquisition Corp. II SPAC
Fenwick represented zSpace, Inc. on the deal. zSpace, Inc., a leading augmented and virtual reality educational technology platform, announced its definitive merger agreement with EdtechX Holdings Acquisition...
Sema4’s Acquisition of GeneDx
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
Nextdoor’s $686 Million Business Combination with Khosla Ventures Acquisition Co. II SPAC
Fenwick & West LLP advised Nextdoor, while Latham & Watkins LLP represented KVSB. Simpson Thacher represented Evercore Group L.L.C. and Morgan Stanley & Co. LLC on...